AngioDynamics (ANGO)

Add to Watchlists Create an Alert
10.71 +0.04  +0.37%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

AngioDynamics R&D Expense Quarterly:

5.793M for Feb. 28, 2013
View Full Chart

AngioDynamics R&D Expense Quarterly Chart

    AngioDynamics Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Feb. 28, 2013 5.793M
    Nov. 30, 2012 7.014M
    Aug. 31, 2012 7.074M
    May 31, 2012 5.222M
    Feb. 29, 2012 4.574M
    Nov. 30, 2011 5.125M
    Aug. 31, 2011 5.591M
    May 31, 2011 5.549M
    Feb. 28, 2011 5.322M
    Nov. 30, 2010 5.259M
    Aug. 31, 2010 5.242M
    May 31, 2010 5.374M
    Feb. 28, 2010 4.289M
    Nov. 30, 2009 4.763M
    Aug. 31, 2009 4.849M
    May 31, 2009 4.835M
    Feb. 28, 2009 4.692M
    Nov. 30, 2008 4.425M
    Aug. 31, 2008 3.962M
       
    May 31, 2008 4.064M
    Feb. 29, 2008 Go Pro
    Nov. 30, 2007 Go Pro
    Aug. 31, 2007 Go Pro
    May 31, 2007 Go Pro
    Feb. 28, 2007 Go Pro
    Nov. 30, 2006 Go Pro
    Aug. 31, 2006 Go Pro
    May 31, 2006 Go Pro
    Feb. 28, 2006 Go Pro
    Nov. 30, 2005 Go Pro
    Aug. 31, 2005 Go Pro
    May 31, 2005 Go Pro
    Feb. 28, 2005 Go Pro
    Nov. 30, 2004 Go Pro
    Aug. 31, 2004 Go Pro
    May 31, 2004 Go Pro
    Feb. 29, 2004 Go Pro
    May 31, 2003 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    ANGO R&D Expense Quarterly Benchmarks

    Companies
    BSD Medical Corporation 0.5587M
    Boston Scientific 204.00M
    C.R. Bard 59.30M

    ANGO R&D Expense Quarterly Rankings

    Overall 89th percentile
    768 of 7600
    Sector 67th percentile
    213 of 653 in Healthcare
    Industry 68th percentile
    21 of 66 in Medical Instruments & Supplies

    ANGO R&D Expense Quarterly Range, Past 5 Years

    Minimum 3.962M Aug 2008
    Maximum 7.074M Aug 2012
    Average 5.151M